APC/Cyanine7 anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APCCy7_072210
C57BL/6 bone marrow cells stained with 1A8 APC/Cyanine7
  • 1A8_APCCy7_072210
    C57BL/6 bone marrow cells stained with 1A8 APC/Cyanine7
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
127623 25 µg 80€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127624 100 µg 243€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Däbritz J, et al. 2016. Sci Rep. 6:20584. PubMed
  2. Zaman R, et al. 2021. Immunity. :. PubMed
  3. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  4. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
  7. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
  8. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
  9. Ivan DC, et al. 2023. Acta Neuropathol Commun. 11:35. PubMed
  10. Chung KJ, et al. 2023. Int J Mol Sci. 24:. PubMed
  11. Houlder E, et al. 2023. Nat Commun. 14:1863. PubMed
  12. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
  13. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  14. Yashchenko A, et al. 2023. Front Immunol. 14:1082078. PubMed
  15. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  16. Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed
  17. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
  18. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  19. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  20. McCauley KE, et al. 2022. Cell Rep Med. 3:100713. PubMed
  21. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  22. Klapproth E, et al. 2022. Nat Commun. 13:7648. PubMed
  23. Chen O, et al. 2023. J Clin Invest. 133: . PubMed
  24. Li J, et al. 2023. Nat Commun. 14:159. PubMed
  25. Xu R 2023. Cell Reports. 42(2):112054. PubMed
  26. Tunali G, et al. 2023. J Clin Invest. :. PubMed
  27. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  28. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  29. Kim EH, et al. 2020. Elife. 9:00. PubMed
  30. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  31. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  32. Regev O, et al. 2022. Front Immunol. 13:849701. PubMed
  33. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  34. Deng J, et al. 2021. JCI Insight. 6:146133. PubMed
  35. Price P, et al. 2014. J Virol. 88:10840. PubMed
  36. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  37. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
  38. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  39. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  40. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
  41. Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed
  42. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  43. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  44. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  45. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  46. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  47. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  48. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
  49. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  50. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  51. Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed
  52. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  53. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  54. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  55. Kovács B, et al. 2020. Front Immunol. 2.508333333. PubMed
  56. Anderson MC, et al. 2018. Cell Chem Biol. 25:483. PubMed
  57. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  58. Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
  59. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  60. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
  61. Woods T, et al. 2016. J Virol. 90: 2783 - 2793. PubMed
  62. Zhang J, et al. 2015. Sci Rep. 5: 15553. PubMed
  63. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  64. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  65. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  66. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  67. Stutz MD, et al. 2021. Immunity. 54(8):1758-1771.e7. PubMed
  68. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  69. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  70. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  71. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  72. Saha S, et al. 2016. Nat Commun. 7:13096. PubMed
  73. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  74. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  75. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  76. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  77. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  78. Wilson R, et al. 2016. Nat Commun. 7:13597. PubMed
  79. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  80. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  81. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  82. Wang SK, et al. 2021. JCI Insight. 6: . PubMed
  83. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  84. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  85. Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed
  86. Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed
  87. Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed
  88. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  89. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  90. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  91. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  92. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  93. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  94. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
  95. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  96. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  97. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  98. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  99. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  100. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  101. Briukhovetska D, et al. 2020. Frontiers in Immunology. 1.428472222. PubMed
  102. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  103. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  104. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  105. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  106. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  107. Ni Y, et al. 2021. Theranostics. 11:9431. PubMed
  108. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  109. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  110. Zhang L, et al. 2020. Cell. 442:181. PubMed
  111. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
  112. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  113. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  114. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
  115. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
  116. Woods PS, et al. 2020. Am J Respir Cell Mol Biol. 62:243. PubMed
  117. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  118. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  119. Dodd RD, et al. 2017. Cancer Res. 77:4486. PubMed
  120. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  121. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  122. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  123. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  124. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  125. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  126. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  127. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  128. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  129. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
RRID
AB_10645331 (BioLegend Cat. No. 127623)
AB_10640819 (BioLegend Cat. No. 127624)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account